X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3461) 3461
Publication (491) 491
Book Review (23) 23
Book Chapter (12) 12
Conference Proceeding (4) 4
Dissertation (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3066) 3066
fusion proteins, bcr-abl - metabolism (1646) 1646
index medicus (1546) 1546
fusion proteins, bcr-abl - genetics (1485) 1485
animals (1281) 1281
oncology (1213) 1213
hematology (1151) 1151
chronic myelogenous leukemia (1128) 1128
mice (994) 994
imatinib mesylate (993) 993
chronic myeloid-leukemia (964) 964
leukemia, myelogenous, chronic, bcr-abl positive - genetics (957) 957
bcr-abl (923) 923
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (836) 836
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (816) 816
benzamides (752) 752
leukemia, myelogenous, chronic, bcr-abl positive - pathology (749) 749
leukemia (706) 706
hemic and lymphatic diseases (645) 645
female (643) 643
chronic myeloid leukemia (635) 635
pyrimidines - pharmacology (626) 626
male (624) 624
apoptosis (557) 557
imatinib (540) 540
piperazines - pharmacology (540) 540
k562 cells (533) 533
cell line, tumor (532) 532
phosphorylation (531) 531
antineoplastic agents - pharmacology (504) 504
cell biology (489) 489
biochemistry & molecular biology (481) 481
fusion proteins, bcr-abl - antagonists & inhibitors (478) 478
cancer (469) 469
adult (468) 468
middle aged (452) 452
mutation (448) 448
apoptosis - drug effects (446) 446
signal transduction (430) 430
research (424) 424
philadelphia-chromosome (420) 420
tyrosine kinase (408) 408
antineoplastic agents - therapeutic use (407) 407
protein kinase inhibitors - pharmacology (406) 406
pyrimidines - therapeutic use (400) 400
tumor cells, cultured (372) 372
piperazines - therapeutic use (356) 356
protein-tyrosine kinases - metabolism (353) 353
protein-tyrosine kinases - antagonists & inhibitors (331) 331
proteins (329) 329
cml (328) 328
cell line (327) 327
drug resistance, neoplasm (318) 318
genetic aspects (317) 317
aged (303) 303
protein kinase inhibitors - therapeutic use (300) 300
gene expression (291) 291
acute lymphoblastic-leukemia (290) 290
expression (283) 283
transfection (269) 269
cell proliferation - drug effects (268) 268
molecular sequence data (264) 264
cells (263) 263
kinases (261) 261
reverse transcriptase polymerase chain reaction (257) 257
base sequence (248) 248
rna, messenger - genetics (247) 247
tyrosine (247) 247
oncogene proteins, fusion - genetics (239) 239
philadelphia chromosome (237) 237
activation (234) 234
resistance (233) 233
rna, messenger - metabolism (231) 231
multidisciplinary sciences (229) 229
fusion protein (228) 228
neoplasms (220) 220
cell proliferation (217) 217
genetics & heredity (215) 215
fusion proteins, bcr-abl - physiology (212) 212
leukemia, myelogenous, chronic, bcr-abl positive - enzymology (212) 212
stem cells (209) 209
article (208) 208
stem-cells (208) 208
blotting, western (204) 204
care and treatment (200) 200
gene (199) 199
research article (198) 198
fusion proteins, bcr-abl - biosynthesis (197) 197
medicine, research & experimental (197) 197
bcr protein (196) 196
fusion proteins, bcr-abl (196) 196
physiological aspects (196) 196
bcr/abl (194) 194
gene expression regulation, leukemic (193) 193
flow cytometry (192) 192
signal transduction - drug effects (189) 189
adolescent (187) 187
dasatinib (185) 185
health aspects (182) 182
hematopoietic stem cells - metabolism (180) 180
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3316) 3316
Chinese (100) 100
Japanese (21) 21
Polish (7) 7
French (5) 5
Hungarian (3) 3
Korean (3) 3
Russian (3) 3
Czech (2) 2
German (2) 2
Spanish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Angewandte Chemie International Edition, ISSN 1433-7851, 01/2016, Volume 55, Issue 2, pp. 807 - 810
Journal Article
Cancer Cell, ISSN 1535-6108, 2009, Volume 16, Issue 5, pp. 401 - 412
Inhibition of BCR-ABL by imatinib induces durable responses in many patients with chronic myeloid leukemia (CML), but resistance attributable to kinase domain... 
CHEMBIO | HUMDISEASE | CHRONIC MYELOGENOUS LEUKEMIA | DASATINIB BMS-354825 | MESYLATE | CML | ONCOLOGY | KINASE DOMAIN MUTATIONS | AMN107 | IMATINIB RESISTANCE | NILOTINIB | Proto-Oncogene Proteins c-abl - antagonists & inhibitors | Humans | Imidazoles - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Crystallography, X-Ray | Pyridazines - pharmacology | Protein Kinase Inhibitors - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Antineoplastic Agents - pharmacology | Fusion Proteins, bcr-abl - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Proto-Oncogene Proteins c-abl - genetics | Cell Growth Processes - drug effects | Proto-Oncogene Proteins c-abl - chemistry | Models, Molecular | Imidazoles - pharmacology | Antineoplastic Agents - chemistry | Mice, SCID | Pyridazines - chemistry | Fusion Proteins, bcr-abl - genetics | Animals | Signal Transduction - drug effects | Fusion Proteins, bcr-abl - antagonists & inhibitors | Cell Line, Tumor | Proto-Oncogene Proteins c-abl - metabolism | Mice | Protein Kinase Inhibitors - pharmacology | Fusion Proteins, bcr-abl - metabolism | Chronic myeloid leukemia | BCR protein | Imatinib | Mutagenesis | Abl protein | Mutation | Fusion protein | Tumors | Index Medicus | imatinib resistance | dasatinib | nilotinib | compound mutation
Journal Article
Blood, ISSN 0006-4971, 02/2012, Volume 119, Issue 6, pp. 1501 - 1510
Journal Article
Cancer Cell, ISSN 1535-6108, 2008, Volume 14, Issue 3, pp. 238 - 249
Resistance of Bcr-Abl-positive leukemic stem cells (LSCs) to imatinib treatment in patients with chronic myeloid leukemia (CML) can cause relapse of disease... 
STEMCELL | CELLCYCLE | CHRONIC MYELOGENOUS LEUKEMIA | HEMATOPOIETIC-CELLS | MOLECULAR REMISSION | ONCOLOGY | SONIC HEDGEHOG | SIGNALING PATHWAY | PHILADELPHIA-CHROMOSOME | NEURAL-TUBE | IMATINIB MESYLATE DISCONTINUATION | MICE | CHRONIC MYELOID-LEUKEMIA | CELL BIOLOGY | Cell Proliferation | Fetal Stem Cells - cytology | Gene Expression - drug effects | Receptors, G-Protein-Coupled - metabolism | Apoptosis - drug effects | Neoplastic Stem Cells - drug effects | Fetal Stem Cells - metabolism | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Hedgehog Proteins - physiology | Hematopoiesis - drug effects | Neoplastic Stem Cells - metabolism | Kruppel-Like Transcription Factors - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Smoothened Receptor | Bone Marrow Transplantation | Veratrum Alkaloids - pharmacology | Neoplastic Stem Cells - pathology | Bone Marrow Cells - drug effects | Hematopoiesis - physiology | Patched Receptors | Drug Therapy, Combination | Veratrum Alkaloids - therapeutic use | Mice, Inbred C57BL | Bone Marrow Cells - pathology | Receptors, Cell Surface - metabolism | Mice, Transgenic | Pyrimidines - pharmacology | Mice, Knockout | Fusion Proteins, bcr-abl - genetics | Animals | Signal Transduction - drug effects | Pyrimidines - therapeutic use | Survival Analysis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Signal Transduction - physiology | Fetal Stem Cells - transplantation | Mice | Receptors, G-Protein-Coupled - genetics | Zinc Finger Protein GLI1 | Kruppel-Like Transcription Factors - genetics | Bone Marrow Cells - metabolism | Fusion Proteins, bcr-abl - metabolism | Receptors, Cell Surface - genetics | Genetic research | Flexible response (Strategy) | Drug resistance | Deterrence (Strategy) | Leukemia | Stem cells
Journal Article
Nature Chemical Biology, ISSN 1552-4450, 03/2012, Volume 8, Issue 3, pp. 285 - 293
Journal Article
Cell, ISSN 0092-8674, 10/2011, Volume 147, Issue 2, pp. 306 - 319
Journal Article
Nature, ISSN 0028-0836, 01/2010, Volume 463, Issue 7280, pp. 501 - 506
In an effort to find new pharmacological modalities to overcome resistance to ATP-binding-site inhibitors of Bcr-Abl, we recently reported the discovery of... 
CELL LUNG-CANCER | KINASE-INHIBITOR | SELECTIVE INHIBITOR | C-ABL | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | DYNAMICS | MUTATIONS | LYMPHOBLASTIC-LEUKEMIA | IMATINIB RESISTANCE | CHRONIC MYELOID-LEUKEMIA | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Transplantation, Heterologous | Piperazines - chemistry | Pyrimidines - chemistry | Pyrimidines - metabolism | Antineoplastic Agents - metabolism | Mass Spectrometry | Bone Marrow Transplantation | Inhibitory Concentration 50 | Female | Antineoplastic Agents - pharmacology | Binding Sites | Disease Models, Animal | Fusion Proteins, bcr-abl - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Protein Structure, Tertiary | Crystallization | Antineoplastic Combined Chemotherapy Protocols | Models, Molecular | Pyrimidines - pharmacology | Antineoplastic Agents - chemistry | Mutation - genetics | Imatinib Mesylate | Piperazines - pharmacology | Fusion Proteins, bcr-abl - genetics | Animals | Cell Line, Tumor | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Mice | Benzamides | Fusion Proteins, bcr-abl - metabolism | Drug Resistance, Neoplasm - drug effects | Nilotinib | Dasatinib | Drug resistance in microorganisms | Usage | Nuclear magnetic resonance spectroscopy | Research | Chronic myeloid leukemia | X-ray crystallography | Chromosome abnormalities | Gene mutations | Analysis | Genetic aspects | Diagnosis | Binding proteins | Drug therapy | Health aspects | Proteins | Studies | Competition | Enzymes | E coli | Kinases | Drug resistance | Crystal structure | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article